Sunder Biomedical Tech. , Ltd. Long Term Debt

The latest long-term debt for 4115.TWO is $110M as of June 2026. That compares with $120M in the prior-year period — down 7.9% year over year. Investors often review this figure alongside Sunder Biomedical Tech. , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 4115.TWO's long-term debt moved from $120M to $110M — a 7.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sunder Biomedical Tech. , Ltd.'s operating scale or balance-sheet position.

A long-term debt figure of $110M for 4115.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 4115.TWO's long-term debt ($110M), review year-over-year change from $120M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.